FINAL 5-YEAR OUTCOMES OF THE EVOLVE II TRIAL: A PROSPECTIVE RANDOMIZED INVESTIGATION OF A NOVEL BIOABSORBABLE POLYMER-COATED, EVEROLIMUS-ELUTING SYNERGY STENT

Dean J. Kereiakes; Stephan Windecker; Robert Jobe; Shamir R. Mehta; Ian Joseph Sarembock; Robert Feldman; Bernardo Stein; Christophe Dubois; Timothy Grady; Shigeru Saito; Dominic Allocco; Ian Meredith

doi:https://doi.org/10.1016/s0735-1097(19)31636-5

doi.org/10.1016/s0735-1097(19)31636-5

FINAL 5-YEAR OUTCOMES OF THE EVOLVE II TRIAL: A PROSPECTIVE RANDOMIZED INVESTIGATION OF A NOVEL BIOABSORBABLE POLYMER-COATED, EVEROLIMUS-ELUTING SYNERGY STENT

Dean J. Kereiakes,

Stephan Windecker,

..., Ian Meredith

1

Journal of the American College of Cardiology24.00

Volume: 73, Issue: 9, Pages: 1029 - 1029

Published: Mar 1, 2019

Abstract

Durable polymers may contribute to increased risk of late thrombotic events and the need for prolonged DAPT as they have been associated with delayed arterial healing, incomplete endothelialization and hypersensitivity. The SYNERGY stent (Boston Scientific Corporation, Marlborough, MA) designed...

Paper Fields

Paper Details

Title

FINAL 5-YEAR OUTCOMES OF THE EVOLVE II TRIAL: A PROSPECTIVE RANDOMIZED INVESTIGATION OF A NOVEL BIOABSORBABLE POLYMER-COATED, EVEROLIMUS-ELUTING SYNERGY STENT

DOI

doi.org/10.1016/s0735-1097(19)31636-5

Published Date

Mar 1, 2019

Journal

Journal of the American College of Cardiology

Volume

73

Issue

9

Pages

1029 - 1029

Citation AnalysisPro

You’ll need to upgrade your plan to Pro

Looking to understand the true influence of a researcher’s work across journals & affiliations?

Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.

Learn more

Notes

History